Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 471.49 0.08%

Quarterly report 2024-Q2
added 08-02-2024

report update icon

Vertex Pharmaceuticals Incorporated Income Statement 2011-2024 | VRTX

Annual Income Statement Vertex Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

110 B 76.1 B 56.6 B 61.4 B 59.1 B 47.6 B 41.4 B 20.6 B 21.9 B 25.9 B 18.5 B 9.46 B 7.12 B

Shares

258 M 256 M 258 M 260 M 257 M 254 M 249 M 245 M 241 M 235 M 225 M 212 M 205 M

Historical Prices

426 297 220 236 219 166 150 73.7 126 119 74.3 41.9 33.2

Net Income

3.62 B 3.32 B 2.34 B 2.71 B 1.18 B 2.1 B 263 M -112 M -556 M -739 M -445 M -107 M 29.6 M

Revenue

9.87 B 8.93 B 7.57 B 6.21 B 4.16 B 3.05 B 2.49 B 1.7 B 1.03 B 580 M 1.21 B 1.53 B 1.41 B

Cost of Revenue

1.26 B 1.08 B 904 M 736 M 548 M 410 M 275 M 210 M - - - - -

Gross Profit

- - - - 3.62 B 2.64 B 2.21 B 1.49 B 908 M 519 M 1.08 B 1.25 B 1.33 B

Operating Income

3.83 B 4.31 B 2.78 B 2.86 B 1.2 B 635 M 123 M 9.94 M -467 M -692 M -610 M 46.7 M 114 M

Interest Expense

-22.8 M -165 M 4.9 M 297 M 58.5 M 72.5 M 69.3 M 4.13 M -6.72 M 30.4 M 6.89 M 16.7 M 38.5 M

EBITDA

4.01 B 4.46 B 2.91 B 2.97 B 1.31 B 736 M 454 M 72.6 M -402 M -578 M -151 M 42.4 M 257 M

Operating Expenses

- - - - 2.41 B 1.97 B 1.82 B 1.48 B 1.37 B 1.16 B 1.28 B 1.24 B 1.11 B

General and Administrative Expenses

1.14 B 945 M 840 M 770 M 658 M 558 M 496 M 433 M 377 M 305 M 362 M 437 M 401 M

All numbers in USD currency

Quarterly Income Statement Vertex Pharmaceuticals Incorporated

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

258 M 258 M 258 M 258 M 258 M 257 M 257 M 256 M 256 M 255 M 254 M 258 M 259 M 259 M 260 M 260 M 260 M 260 M 258 M 257 M 256 M 256 M 255 M 255 M 254 M 253 M 252 M 250 M 248 M 246 M 245 M 245 M 244 M 244 M 243 M 242 M 241 M 239 M 238 M 236 M 234 M 233 M 231 M 231 M 222 M 215 M 215 M 214 M 211 M 208 M 207 M 206 M 204 M 202 M

Net Income

-3.59 B 1.1 B - 1.04 B 916 M 700 M - 930 M 810 M 762 M - 852 M 66.9 M 653 M 604 M 667 M 837 M 603 M 583 M 57.5 M 267 M 269 M 1.55 B 129 M 207 M 210 M 101 M -103 M 18 M 248 M 32.9 M -38.8 M -64.5 M -41.6 M -73.7 M -95.1 M -189 M -199 M -177 M -170 M -159 M -232 M 44.3 M -124 M -57.2 M -308 M -76.1 M -57.5 M -64.9 M 91.6 M 159 M 221 M -174 M -176 M

Revenue

2.65 B 2.69 B - 2.48 B 2.49 B 2.37 B - 2.33 B 2.2 B 2.1 B - 1.98 B 1.79 B 1.72 B 1.63 B 1.54 B 1.52 B 1.52 B 1.41 B 950 M 941 M 858 M 870 M 785 M 752 M 641 M 652 M 578 M 544 M 715 M 459 M 414 M 432 M 398 M 418 M 310 M 166 M 139 M 145 M 179 M 138 M 118 M 351 M 222 M 311 M 328 M 334 M 336 M 418 M 439 M 563 M 659 M 114 M 73.7 M

Cost of Revenue

372 M 343 M - 319 M 309 M 267 M - 289 M 262 M 246 M - 236 M 228 M 192 M 203 M 186 M 185 M 162 M 185 M 132 M 136 M 95.1 M 122 M 111 M 104 M 71.6 M 84.1 M 72.9 M 71.2 M 47 M - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-3.51 B 1.14 B - 1.04 B 1.03 B 779 M - 1.13 B 1.11 B 1.04 B - 1.05 B -38 M 888 M 746 M 672 M 718 M 720 M 551 M 99.3 M 270 M 277 M 128 M 206 M 173 M 129 M 126 M -326 M 52.7 M 271 M 39.6 M -18.7 M 3.35 M -14.3 M -53.7 M -70 M -171 M -172 M -154 M -142 M -181 M -216 M -10.3 M -124 M -47 M -429 M -77.5 M -1.07 M -10.8 M 91.6 M 224 M 216 M -166 M -160 M

Interest Expense

-23.1 M -31.2 M - -15.9 M 1.6 M 1.3 M - 17.2 M -78.1 M -72.8 M - 42.4 M 8.05 M -52.7 M 16.3 M 13.9 M 13.9 M 14.1 M 14.2 M 14.5 M 14.8 M 14.9 M 18.7 M 18.7 M 18.2 M 16.9 M -748 K -77.6 M -2.54 M -544 K 1.1 M -167 K -1.22 M 4.41 M -1.69 M -1.33 M 1.41 M -5.11 M -3.79 M -3.99 M 37.7 M 451 K 3.34 M 4.76 M -34 K -1.18 M 33 K -13 K -179 K -150 K 12.4 M 7.06 M 6.96 M 12 M

EBITDA

- 1.19 B - - - 818 M - 1.24 B 1.11 B 1.08 B - 1.15 B -38 M 917 M 746 M 752 M 772 M 747 M 551 M 180 M 325 M 304 M 128 M 259 M 207 M 145 M 126 M -281 M 82.4 M 286 M 39.6 M 27.2 M 34.7 M 2.08 M -53.7 M -23.4 M -141 M -156 M -154 M -95.3 M -151 M -200 M -10.3 M -92.8 M -25.8 M -418 M -77.5 M 24.7 M 6.46 M 100 M 224 M 241 M -148 M -151 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

372 M 343 M - 264 M 263 M 241 M - 247 M 215 M 215 M - 198 M 195 M 192 M 212 M 185 M 192 M 182 M 195 M 160 M 157 M 147 M 153 M 137 M 137 M 130 M 135 M 121 M 127 M 113 M 110 M 106 M 112 M 105 M 96.5 M 99.8 M 94.4 M 85.9 M 78.5 M 75.2 M 77.4 M 74.2 M 73.1 M 86.4 M 105 M 91.6 M 110 M 97.7 M 118 M 111 M 122 M 111 M 96.7 M 71.5 M

All numbers in USD currency